MedTrace Logo

Epidural Anesthesia-analgesia and Long-term Survival After Lung Cancer Surgery

NCT02801409 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2020-08-27

No results posted yet for this study

Summary

Available studies suggest that regional anesthesia-analgesia may decrease the occurrence of recurrence/metastasis in patients after cancer surgery. However, evidences from prospective studies are still lacking. The purpose of this randomized controlled trial is to investigate the effect of epidural anesthesia-analgesia on recurrence-free survival in patients undergoing lung cancer surgery.

Conditions

  • Lung Cancer
  • Thoracic Surgery
  • Anesthesia, Epidural
  • Neoplasm Recurrence, Local
  • Neoplasm Metastasis

Interventions

DRUG

General anesthesia alone

General anesthesia is performed during surgery; patient-controlled intravenous analgesia is provided after surgery.

DRUG

Combined epidural-general anesthesia

Combined epidural-general anesthesia is performed during surgery; patient-controlled epidural analgesia is provided after surgery.

Sponsors & Collaborators

  • Peking University First Hospital

    lead OTHER

Principal Investigators

  • Dong-Xin Wang, MD, PhD · Peking University First Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-25
Primary Completion
2017-11-11
Completion
2019-11-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02801409 on ClinicalTrials.gov